Mustang Bio (MBIO) Free Cash Flow (2016 - 2026)
Mustang Bio (MBIO) posted quarterly Free Cash Flow of -$1.0 million for Q1 2026, up 27.43% year-over-year from -$791023.7 in Q1 2025, and up 41.33% quarter-over-quarter from -$1.7 million in Q4 2025.
Mustang Bio (MBIO) Free Cash Flow (2016 - 2026) Analysis & Trends
Mustang Bio (MBIO) has reported Free Cash Flow for 11 consecutive years, with -$1.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 27.43% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$4.9 million (up 34.7% YoY), while the FY2025 annual figure was -$5.3 million, up 53.87% from the prior year.
- Free Cash Flow advanced to -$1.0 million in Q1 2026 per MBIO's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$818000.0 in Q3 2025 and bottomed at -$19.2 million in Q2 2022.
- Historically, Free Cash Flow has averaged -$7.9 million across 5 years, with a median of -$5.3 million in 2024.
- Annual changes were most pronounced in 2022 — Free Cash Flow sank 43.77% — and 2024, when it soared 85.39%.
- Mustang Bio's Free Cash Flow stood at -$15.4 million in 2022, then surged by 52.65% to -$7.3 million in 2023, then surged by 72.58% to -$2.0 million in 2024, then grew by 13.97% to -$1.7 million in 2025, then soared by 41.33% to -$1.0 million in 2026.
- Business Quant data shows MBIO's Free Cash Flow at -$1.0 million in Q1 2026, -$1.7 million in Q4 2025, and -$818000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | -967,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -967,000.00 |
| Jun 30, 2026 | -967,000.00 |
| Mar 31, 2026 | -1.01 Mn |
| Mar 31, 2026 | -1.01 Mn |
| Dec 31, 2025 | -1.72 Mn |
| Dec 31, 2025 | -1.72 Mn |
| Sep 30, 2025 | -818,000.00 |
| Sep 30, 2025 | -818,000.00 |
| Jun 30, 2025 | -1.34 Mn |
| Jun 30, 2025 | -1.34 Mn |
| Mar 31, 2025 | -1.39 Mn |
| Mar 31, 2025 | -1.39 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -2.34 Mn |
| Jun 30, 2024 | -2.34 Mn |
| Mar 31, 2024 | -5.32 Mn |
| Mar 31, 2024 | -5.32 Mn |